Hoba Therapeutics ApS: Financial statements 2020
CVR: 38231170
Source: annual report 2020, Danish Business Authority
01/04/2019 – 31/03/2020
Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 838,894 and a net result of DKK -1,582,107 compared with DKK -1,145,346 the year before. That is an increase of 183.3% compared with the year before. Equity in the 2020 report amounted to DKK 10,128,327. The solvency ratio was 41.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 838,894
- Profit/Loss
- DKK -1,582,107
- Equity
- DKK 10,128,327
- Total Assets
- DKK 24,309,356
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 839K | -1.6M | 10.1M | 2 |
| 2019 | - | 296K | -1.1M | 11.7M | - |
| 2018 | - | 485K | -892K | 8.9M | - |
Official annual report
How creditworthy is Hoba Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of July 1, 2020, Torsten Meldgaard Madsen is registered as adm. dir. of Hoba Therapeutics ApS.
As of July 1, 2020, Kenneth Ahrend Petersen has stepped down as adm. dir. of Hoba Therapeutics ApS.
As of January 31, 2020, Thor Jespersen has joined the board of directors of Hoba Therapeutics ApS.
As of January 31, 2020, Steen Palle Petersen has left the board of directors of Hoba Therapeutics ApS.
About Hoba Therapeutics ApS
Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.
